摘要
特定地理区域人群使ad hoc基因型与表型的相关性研究为疾病提供新的和独特的见解。作为正在进行的纵向研究的一部分,我们分析了利古里亚(意大利北部)早期和晚发型阿尔茨海默病(EOAD和LOAD)相关的遗传风险因素。我们筛选了37个AD、8个轻度认知障碍者(MCI)、3个AD与心血管疾病患者(CVD)、3个轻度认知障碍(MCI)和心血管疾病(CVD)患者、8个额颞叶痴呆(FTD)和2个进行性核上性麻痹(PSP)患者以及一个由28正常人组成的控制组(NCs)。我们对所有病例和正常控制组的PSEN1、PSEN2、APP(EOAD风险因素)、MAPT、GRN和TARDBP进行测序并为27个AD患者、45个AD和MCI患者以及控制组的28个正常人分析了APOE、CLU、CR1和PICALM基因型以及MAPT和ACE单倍型(LOAD风险因素)。我们发现PSEN1、PSEN2和TARDBP的变种横跨一系列表型(AD、AD和 CVD、FTD和PSP),这表明对阿尔茨海默氏症和非阿尔茨海默病痴呆表现形式的所有已知候选基因的筛选是必要的。对LOAD风险因素的分析表明经过Bonferroni校正后它与AD或者AD和MCI并没有关联,之前对意大利人的研究证明了这与APOE没有关系。我们的数据也证明:1)在PSEN2位点存在潜在的保护单倍型;2)与CR1基因(rs3818361)GWAS的风险等位基因A 的名义相关;3)女性AD的患病率是男性的三倍。我们的研究结果需要在该地区大量的人群中做进一步评估和证实。
关键词: EOAD,性别,基因分型,LOAD,种群特异性,风险因素,测序。
Current Alzheimer Research
Title:Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Volume: 12 Issue: 8
Author(s): Raffaele Ferrari, Michela Ferrara, Anwar Alinani, Roger Brian Sutton, Francesco Famà, Agnese Picco, Guido Rodriguez, Flavio Nobili and Parastoo Momeni
Affiliation:
关键词: EOAD,性别,基因分型,LOAD,种群特异性,风险因素,测序。
摘要: Cohorts from a defined geographical area enable ad hoc genotype-phenotype correlation studies providing novel and unique insight into disease. We analysed genetic risk factors associated with early and late onset Alzheimer’s disease (EOAD and LOAD) in a population from Liguria (northern Italy), as part of an ongoing longitudinal study. We screened 37 AD, 8 mild cognitive impairment (MCI), 3 AD and CVD (cerebrovascular disease), 3 MCI and CVD, 8 frontotemporal dementia (FTD) and 2 progressive supranuclear palsy (PSP) patients, and 28 normal controls (NCs).We sequenced PSEN1, PSEN2 and APP (EOAD risk factors), as well as MAPT, GRN and TARDBP for all cases and NCs, and analysed the APOE, CLU, CR1 and PICALM genotypes as well as the MAPT and ACE haplotypes (LOAD risk factors) for the AD (n = 37) and AD + MCI (n = 45) cases and NCs (n = 28).We identified variants in PSEN1, PSEN2 and TARDBP across a range of phenotypes (AD, AD and CVD, FTD and PSP), suggesting that screening of all known candidate genes of Alzheimer’s and non-Alzheimer’s forms of dementias in all dementia cases might be warranted. The analysis of the LOAD risk factors revealed no association with AD or AD + MCI status after Bonferroni correction. Lack of association with APOE is supported by previous studies in the Italian population. Our data also evidenced: 1) a potentially protective haplotype at the PSEN2 locus; 2) a nominal association with the GWAS-risk allele A for rs3818361 in CR1 and; 3) a threefold prevalenceof AD in the femalepopulation compared to men.Our results will need to be further assessed and confirmed in larger cohorts from this area.
Export Options
About this article
Cite this article as:
Ferrari Raffaele, Ferrara Michela, Alinani Anwar, Brian Sutton Roger, Famà Francesco, Picco Agnese, Rodriguez Guido, Nobili Flavio and Momeni Parastoo, Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy, Current Alzheimer Research 2015; 12 (8) . https://dx.doi.org/10.2174/1567205012666150710114751
DOI https://dx.doi.org/10.2174/1567205012666150710114751 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Current Alzheimer Research Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Current Immunology Reviews (Discontinued) Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient
CNS & Neurological Disorders - Drug Targets Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia
Current Pharmaceutical Design Potential for Stem Cells Therapy in Alzheimer’s Disease: Do Neurotrophic Factors Play Critical Role?
Current Alzheimer Research The Clinical and Biological Relationship between Type II Diabetes Mellitus and Alzheimers Disease
Current Alzheimer Research Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases
CNS & Neurological Disorders - Drug Targets The Relationship between Inflammatory and Oxidative Stress Biomarkers, Atherosclerosis and Rheumatic Diseases
Current Pharmaceutical Design NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimers Disease
Current Pharmaceutical Design Editorial [Hot Topic: Exploring the Links between Obesity and Alzheimers Disease (Guest Editor: Suzana S. Petanceska) ]
Current Alzheimer Research Subcellular Injuries in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
Current Medicinal Chemistry Sculpted Amphiphilic Liposomal Particles for Modifiable Medicinal Applications
Current Drug Discovery Technologies Placebo Preparation for the Proper Clinical Trial of Herbal Medicine - Requirements, Verification and Quality Control
Recent Patents on Inflammation & Allergy Drug Discovery Role of DAP12 in Innate and Adaptive Immune Responses
Current Pharmaceutical Design Conference Report (8th Annual Meeting of the Society for the Study of Neuroprotection and Neuroplasticity)
CNS & Neurological Disorders - Drug Targets Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Preeclampsia and the Future Development of Cardiovascular Disease: A Review
Current Women`s Health Reviews Editorial (Thematic Issue: Disease Control and Active and Healthy Ageing: New Paradigms of Therapeutic Strategy)
Current Pharmaceutical Design Stem Cell Patents: An Innovative Approach to Anti-Cancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery